At all time points CD69+ EVs were significantly higher in patients who developed GVHD (mean fold 9.01 +/- 1.33; p = 2.1e-5, GLM for repeated measure, F = 11.381, p = 0.003, Figure 5C). Here, CD69 is linked to graft versus host disease.